Navigation Links
Hologic Announces First Quarter Fiscal 2013 Operating Results
Date:2/4/2013

the reconciliations of these historical measures to the Company's comparable GAAP financial measures for the periods presented, are set forth in the supplemental information attached to this press release. When analyzing the Company's operating performance, investors should not consider these non-GAAP measures as a substitute for the comparable financial measures prepared in accordance with GAAP.

"Looking ahead, we believe Hologic's diverse, innovative products will continue to gain traction in the marketplace by exceeding the expectations of our customers and addressing the needs of our patients," said Rob Cascella. "We have leadership across our business segments and the resources and capabilities to support our long-term growth strategy."

First Quarter Fiscal 2013 Revenue Overview by Segment (As Compared to the First Quarter Fiscal 2012):

  • Diagnostics revenues totaled $305.9 million in the current quarter, net of the $13.3 million reduction primarily for the effect of purchase accounting related to Gen-Probe's collaboration agreement with Novartis that was eliminated under GAAP, compared to $154.1 million in the prior year. Including the $13.3 million, non-GAAP adjusted revenues totaled $319.2 million, an increase of 107.2%. Sales growth was driven primarily by the inclusion of Gen-Probe revenues for a full quarter and, to a lesser extent, strong growth in Hologic's legacy molecular diagnostics revenues as well as an increase in international ThinPrep sales.
  • Breast Health revenues totaled $220.8 million in the current quarter compared to $215.4 million in the prior year, an increase of 2.5%. Revenue growth was driven by an $8.6 million, or 12.2%, increase in service revenues from the Company's growing installed base of digital mammography systems, partially offset by a reduction in product revenues of $3.2 million, or 2.2%.
  • GYN Surgical revenues totaled $80.9 million in the current quarter compared to $78.5 million in t
    '/>"/>

  • SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
    2. Hologic to Release Third Quarter Fiscal 2012 Operating Results on Monday, July 30, 2012
    3. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
    4. Hologic, Inc. Announces Note Offering
    5. Hologic And Gen-Probe Provide Update On Pending Transaction
    6. Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologics Acquisition of Gen-Probe
    7. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
    8. Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
    9. Hologic Announces Third Quarter Fiscal 2012 Operating Results
    10. Hologic Completes Acquisition Of Gen-Probe
    11. Senator Blumenthal, a Strong Advocate for Womens Health, Visits Hologics Manufacturing Facility in Danbury, CT
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... -- STAAR Surgical Company (NASDAQ: STAA ), a leading developer, ... the eye today reported financial results for the second quarter ... , Net Sales of $18.7 Million Down 7% from ... $2.1 Million from the Weakening Euro and Yen , ... , APAC Sales Down 1% Including Korea - Up ...
    (Date:7/29/2015)... 29, 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the second quarter ended June 30, 2015. ... HETLIOZ and Fanapt" said Mihael H. Polymeropoulos M.D., Vanda,s ... life cycle management of our products set the stage ... Financial Highlights , Total net product ...
    (Date:7/29/2015)... NEWARK, Calif. , July 29, 2015 /PRNewswire/ ... "Company") today announced that its Board of Directors, ... its independent financial and legal advisors, has unanimously ... non-binding proposal from Horizon Pharma plc (NASDAQ: ... outstanding shares of Depomed in an all-stock transaction ...
    Breaking Medicine Technology:STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 12Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 13
    ... PARK, Calif., March 22, 2011 Telome Health, Inc. ... property portfolio. THI will provide telomere length data from ... health monitoring. THI leverages the predictive ... protective caps at the ends of chromosomes, to assess ...
    ... MOUNT PROSPECT, Ill., March 22, 2011 The National Association ... the prescription monitoring programs (PMPs) of North Dakota , ... agreements to participate in the PMP Interconnect ™ system, ... United States to be linked, providing a more effective means ...
    Cached Medicine Technology:Telome Health, Inc. Launches With Exclusive IP Portfolio 2Telome Health, Inc. Launches With Exclusive IP Portfolio 3Three States Sign on to Participate in NABP's Interconnected Prescription Monitoring System 2Three States Sign on to Participate in NABP's Interconnected Prescription Monitoring System 3
    (Date:7/29/2015)... New Port Richey, FL (PRWEB) , ... July ... ... across the nation have become increasingly aware of the impact drinking and substance ... morale, and increased illness. Financial loss is tagged in the billions per year. ...
    (Date:7/29/2015)... ... , ... " Core Organizer ” was featured on NewsWatch as part of ... the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and ... help anyone get organized. , Wouldn’t it be great if everyone could be a ...
    (Date:7/29/2015)... ... 29, 2015 , ... More than 28,000 students in Pennsylvania ... living with autism will converge upon Penn State to share the latest updates ... Autism Conference will be held Aug. 3-6 at the Penn Stater Conference Center ...
    (Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business ... is directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same ... of the National academy of Sciences, and has given researchers inklings to explore Rsu1 ...
    (Date:7/29/2015)... ... 29, 2015 , ... With a new community program in ... Cancer Support Services and announced a new charity campaign to raise funds to ... groups, workshops and educational programs at no charge. Scott Campbell Agency initiates ...
    Breaking Medicine News(10 mins):Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Get More Organized with the Core Organizer App 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3
    ... Statement of Michael Bender, Plaintiff, WASHINGTON, June 5 ... Administration has finally agreed to comply with the law,and ... substance that poses a,health risk to pregnant women and ... this week, our lawsuit, Moms,Against Mercury et al. v. ...
    ... four-week and seventeen-week periods ended May 29,2008., ... Periods ended May 29, 2008 ... Month Year to Date (Dollars in millions) ... weeks), Total retail drug store sales ...
    ... Medical Corp.,(Nasdaq Capital Market: ESMC) announced today that ... Scientific, Inc. ("Drew") acquired JAS,Diagnostics, Inc. ("JAS"). JAS ... in vitro diagnostics ("IVD") reagents that markets its ... the,world. JAS, based in Miami, Florida, generates annual ...
    ... Health Magazine, SEATTLE, June 5 Kagome, one ... Mango Orchard natural 100 percent juice,blend have been named ... With the help of top health experts, Health ... fitness to the ultimate test,and unveiled a total of ...
    ... a lower cost tool than MRI for evaluating new ... News) -- Researchers say they can cheaply and easily ... off a tumor,s blood supply by using the same ... a technique called bioluminescence imaging (BLI), the University of ...
    ... Massachusetts School of,Professional Psychology, WEST ROXBURY, Mass., ... about the ,invisible wounds of war, - the ... and post traumatic,stress disorder (PTSD) - which raise ... suicide. We need to begin focusing on their,recuperation ...
    Cached Medicine News:Health News:US FDA Admits Risks of Mercury Dental Fillings, Settles Lawsuit 2Health News:Longs Reports Preliminary May Retail Drug Store Sales 2Health News:Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics 2Health News:Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics 3Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 3Health News:Tracking Cancer Drug's Effectiveness 2Health News:Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans 2
    Anti-Tg and Anti-TPO are two major autoantibodies implicated in autoimmune related thyroiditis and aid in the differential diagnosis of Hashimoto's thyroiditis and Graves' disease....
    ... is an automated, turbidimetric, whole- blood assay ... the ability of activated platelets to bind ... of the VerifyNow IIb/IIIa assay device contains ... this analysis. Within the well is an ...
    ... The Company's first commercial product is ... with single-use, disposable assay devices . The ... products are direct use of a vacuum-type ... a result in minutes. VerifyNow IIb/IIIa, the ...
    ... ComboMap system provides both pressure and ... singly or in a combined screen ... SmartWire and Volcano's unique Doppler FloWire. ... valuable tools to assess ambiguous or ...
    Medicine Products: